VIP
GSK icon

Vantage Investment Partners’s GSK GSK Stock Holding History

Vantage Investment Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-228,129
Closed -$12.3M – 72
2017
Q2 		$12.3M Buy
228,129
+12,603
+6% +$672K 1.12% 24
2017
Q1 		$11.4M Buy
215,526
+184,271
+590% +$9.35M 1.26% 24
2016
Q4 		$1.5M Sell
31,255
-172,944
-85% -$8.54M 0.2% 43
2016
Q3 		$11M Buy
+204,199
New +$11.2M 1.42% 26

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Vantage Investment Partners's GSK Position: Q3 2017 in Review

Vantage Investment Partners sold out of GSK (GSK) in Q3 2017, closing a stake of 228,129 shares — an estimated $12.3M sold.

Vantage Investment Partners first reported a position in GSK in Q3 2016 and held it in 4 quarters. The position peaked at $12.3M in Q2 2017. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

  • Vantage Investment Partners reported no remaining GSK position as of Q3 2017 after selling out during the quarter.
  • Vantage Investment Partners sold 228,129 GSK shares in Q3 2017, an estimated $12.3M.
  • Vantage Investment Partners first reported a position in GSK in Q3 2016 and held it in 4 quarters.
  • Vantage Investment Partners's GSK position peaked at $12.3M in Q2 2017.
  • 741 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on Vantage Investment Partners's 13F filing for Q3 2017, filed 14 Nov 2017.